People who had a confirmed case of COVID-19 during the pandemic's first wave have twice the risk of heart attack, stroke and death compared to those who were never infected, according to research funded by the National Institutes of Health.
Author: Paige Twenter
The decadelong reduction in heart failure deaths has "been entirely undone" in recent years, according to a research letter published April 24 in JAMA Network.
Northwell Health has tapped Andrew Krumerman, MD, to be its director of cardiac electrophysiology for Mount Kisco, N.Y.-based Northern Westchester Hospital.
The American Heart Association plans to unveil a new heart disease risk calculator where race is no longer considered a factor.
The American Heart Association plans to unveil a new heart disease risk calculator where race is no longer considered a factor.
Advertisement
Marlex Pharmaceuticals recalled two lots of digoxin tablets, which are used to treat heart failure, because of swapped labels for the 0.25 milligram and 0.125 milligram solutions, the FDA said Aug. 31.
The oral drug muvalaplin saw positive results in the first phase 1 study involving health participants for lipoprotein, a genetic marker for cardiovascular disease that's known for "sticky" cholesterol.
Novo Nordisk's weight loss drug Wegovy reduced heart failure-related symptoms in a phase 3 study, the drugmaker said Aug. 25.
Abbott's Amplatzer Amulet Left Atrial Appendage Occluder was approved nearly two years ago. Here are five things to know about the minimally invasive device:
New York City-based Mount Sinai Health System achieved a healthcare "first" with the world's smallest heart pump, the device's manufacturer said June 7.